Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Nichi-Iko

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Nichi-Iko's Japan sales performance.

BMS scores first oesophageal cancer nod for Opdivo in Japan

BMS scores first oesophageal cancer nod for Opdivo in Japan Approval in Japan comes before US okay. Bristol-Myers Squibb has won its first approval for Opdivo in oesophageal cancer, with an approval in Japan coming before a nod in the ... US. . Japan’s Ministry of Health, Labor and Welfare (MHLW) approved

Incyte’s JAK inhibitor cream clears second eczema trial

Incyte’s JAK inhibitor cream clears second eczema trial Incyte has said it intends to market ruxolitinib cream itself in the US if approved, but may seek partnerships in other territories such as Europe and Japan.

Pfizer’s Vyndaqel is first EU therapy for ATTR cardiomyopathy

Pfizer’s Vyndaqel is first EU therapy for ATTR cardiomyopathy The drug has also been approved for the cardiomyopathy indication in Japan, Brazil and Canada.

FDA sets Q3 decision date for NS Pharma’s DMD drug

FDA sets Q3 decision date for NS Pharma’s DMD drug phase 1/2 study in Japan. ... NS Pharma and its parent company Nippon Shinyaku are currently enrolling patients for a phase 3 study in Japan and the US – named RACER53.

China’s BrightGene successfully copies Gilead’s coronavirus hopeful remdesivir

China’s BrightGene successfully copies Gilead’s coronavirus hopeful remdesivir A Chinese state-owned news agency – Xinhua – has reported that trials have already officially launched, following the approval by China’s National Medical Products Administration of applications by the China-Japan

[ Previous 5 results ] 2 3 4 5 6 7 8 9 10 11 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Madmicrobe Studios

MadMicrobe is an award-winning team of animators and science experts creating photo real life-science animation content for the healthcare and...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics